Correlation between the Characteristics of Chronic Kidney Disease Patients Undergoing Hemodialysis and Erythropoietin Stimulating Agent Therapy and Hemoglobin Levels
DOI:
https://doi.org/10.26911/theijmed.2024.09.02.02Abstract
Background: Chronic Kidney Disease is one of the deadliest diseases in the world with a high prevalence. Hemodialysis is believed to increase the survival of chronic kidney disease patients. This study aims to analyze the relationship between condition factors in patients with chronic kidney disease undergoing hemodialysis and erythropoietin stimulating agent therapy with hemoglobin levels.
Subjects and Method: This research is a quantitative study with a cross-sectional study design carried out at the Madiun City Regional Hospital. Data was taken from June 1, 2022 to June 30, 2022. The population in this study were patients who received hemodialysis services and erythropoietin stimulating agent therapy. The sample was 101 patients with total sampling technique. The independent variables in this study are age, gender, duration of hemodialysis, while the dependent variable is hemoglobin level. Data collection techniques were carried out using patient medical record data. Data analysis used multiple linear regression with Stata 17.
Results: The results of multiple linear regression analysis of the relationship between duration of hemodialysis, gender, age, hemoglobin levels before and hemoglobin levels after chronic kidney disease patients undergoing hemodialysis with erythropoietin stimulating agent therapy show that every 1 month increase in hemodialysis will be followed by an increase in hemoglobin of 0.02g/dL (b =0.02 CI95% 0.01 to 0.03 p=0.018). Every 1g/dL increase in hemoglobin levels before hemodialysis will be followed by hemoglobin levels after hemodialysis of 0.7 g/dL (b=0.7 CI 95% 0.6 to 0.8 p<0.001). Gender (b=-0.06 CI 95% -0.7 to 0.6 p=0.857). Age (b=-0.01 CI 95% -0.03 to 0.03 p=0.833).
Conclusion: There is a positive relationship between the duration of hemodialysis and hemoglobin levels after chronic kidney disease patients undergo hemodialysis with erythropoietin stimulating agent therapy. There is no statistically significant difference between men and women, age in hemoglobin levels after undergoing hemodialysis with erythropoietin stimulating agent therapy in patients with chronic renal failure.
Keywords: chronic kidney disease, hemodialysis, erythropoietin stimulating agent, hemoglobin
References
Aisara S, Azmi S, Yanni M (2018). Gam-baran klinis penderita penyakit ginjal kronik yang menjalani hemodialisis di rsup dr. m. djamil padang (Clinical picture of chronic kidney disease sufferers undergoing hemodialysis at Dr. Hospital. m. Djamil Padang). Andalas Med J. 7(1): 42. doi: 10.250-77/jka.v7i1.778.
Almaeen AH, Hedeab MG (2021). Haema-tological indicators of response to erythropoietin therapy in chronic renal failure patients on haemodialysis: Impact of angio-tensin-converting enzyme rs4343 gene polymorphism. Pharma-coge-nomics and Personalized Medicine, 14 (March): 1055–1068.doi: 10.21-47/PGPM.- S311181.
Amudi T, Palar S (2021). Gagal ginjal kronik hemodialisis dengan kadar eritropoietin dan hemoglobin normal: Laporan Kasus (Hemodialysis chronic renal failure with normal erythropoietin and hemoglobin levels: Case Report). Med Scope J. 2(2): 73–77. doi: 10.35790/msj.2.2.2021.32547.
Ayesh MH, Bataineh A, Elamin E, Khader Y, Alawneh K, Rababah M (2014). Adequate hemodialysis improves anemia by enhancing glucose-6-phosphate dehydrogenase activity in patients with end-stage renal disease. BMC Nephrology. 15:155. Available at: http://www.biomedcentral.com/-1471-2369/15/155
Dewi NN, Suwendar S, Lestari F (2020). Review literatur dari perbandingan efektivitas pemberian epoetin alfa dan epoetin beta terhadap parameter hematologi pada pasien penyakit ginjal kronis yang menjalani hemodialisis (Literature review comparing the effectiveness of epoetin alfa and epoetin beta on hematological parameters in chronic kidney disease patients undergoing hemodialysis). Prosiding Farmasi. 6(2): 1105–1109. Available at: http://karyailmiah.unisba.ac.id/index.php/farmasi/article/view/24342.
Dwitarini NME, Herawati S, Subawa AAN (2017). Perbedaan kadar hemoglobin sebelum dan sesudah hemodialisis pada pasien penyakit ginjal kronis di rumah sakit umum pusat sanglah denpasar bali (Differences in hemo-globin levels before and after hemo-dialysis in chronic kidney disease patients at the Sanglah Central General Hospital, Denpasar, Bali). e-J Med. 6(4): 56-62.
Faizah RN, Azizah NF, Purwoko H (2022). Perbedaan efektifitas terapi eritropo-etin alfa dan beta pada pasien hemo-dialisis reguler di rsud sidoarjo (Differences in the effectiveness of alpha and beta erythropoietin therapy in regular hemodialysis patients at Sidoarjo Hospital). Majalah Farmaseutik. 18(1): 65. doi: 10.22146/farmaseutik.v18i1.71- 914.
Garini A (2018). Kadar hemoglobin pada pasien gagal ginjal kronik yang menjalani hemodialysis (Hemoglobin levels in chronic renal failure patients undergoing hemodialysis). Palembang Polytechnic Health J. 13 (2)
Hasneli YB (2017). Hubungan lama men-jalani hemodialisis dengan inter-dia-lytic weight gain (IDWG) pada pasien hemodialisis long-term relationship in hemodialysis with inter-dialytic weight gain (IDWG) pada pasien hemodialisis (Relationship between length of time undergoing hemodialysis and inter-dialytic weight gain (IDWG) in hemodialysis patients long-term relationship in hemodialysis with inter-dialytic weight gain (IDWG) in hemodialysis patients). Padjajaran University Nurs J. 5(3): 242–248. Available at: jkp.fkep.unpad.ac.id/index.-php/jkp/article/view/646.
Kurniawanto R, Ulfa NM, Hartono R (2018). Studi profil penggunaan eritropoetin (epo) pada pasien penyakit ginjal kronis (pgk) yang menjalani hemodialisa di rumah sakit bhayangkara h.s. samsoeri mertojoso surabaya (Study of the profile of erythropoietin (EPO) use in chronic kidney disease (CKD) patients undergoing hemodialysis at Bhayangkara H.S Hospital. Samsoeri Mertojoso Surabaya).
Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, et al (2007). Chronic kidney disease as a global public health problem: Approaches and initiatives – a posi-tion statement from Kidney Disease Improving Global Outcome. Kidney International. 72: 247–259; doi:10.-1038/sj.ki.5002343.
Mailani F (2017). Kualitas hidup pasien penyakit ginjal kronik yang menjalani hemodialisis: Systematic Review (Quality of life in chronic kidney disease patients undergoing hemodialysis: Systematic Review). NERS J. 11(1). doi: 10.25077/njk.-11.1.1-8.2015.
PERNEFRI (2011). Konsensus manajemen anemia pada penyakit ginjal kronik (Consensus on management of anemia in chronic kidney disease). J of Chemical Inf and Modeling.
PERNEFRI (2015). 8th Report of indone-sian renal registry 2018. Indonesian Renal Registry (IRR). 1–45. Available at:https://www.indonesian-renal-regis-try.org/data/indonesian%20renal%20registry%202015.pdf.
PERNEFRI (2018). 11th Report of indone-sian renal registry 2018. Indonesian Renal Registry (IRR). 1–46. Available at:https://www.indonesian- renalregistry.org/data/IRR 2018.pdf.
Pranandari R, Supadmi W. (2015). Faktor risiko gagal ginjal kronik di unit hemodialisis rsud wates kulon progo (Risk factors for chronic kidney failure in the hemodialysis unit at Wates Kulon Progo Hospital). Majalah Farmaseutik. 11(2). https://doi.org/10.22-146/farmaseutik.v11i2.24120.
Puspita AA, Setianingrum ELS, Lidia K (2019). Pengaruh frekuensi hemodia-lisis terhadap perbedaan kadar hemoglobin dan indeks eritrosit pasien gagal ginjal kronik pre dan post hemodialisis di rsud prof. dr. w. z. johannes tahun 2018 (The influence of hemodialysis frequency on differences in hemoglobin levels and erythrocyte indices in pre- and post-hemodialysis chronic kidney failure patients at Prof. Hospital. Dr. w. z. Johannes in 2018). Cendana Med J. 7(1): 102–111. http://-ejurnal.undana.ac.id/CMJ/article/-view/1462.
Putri NM, Astuti TD. (2020). Literature study: analysis of hemoglobin levels before and after hemodialysis in chronic renal failure. Universitas ‘Aisyiyah Yogyakarta 36: 2011-2019
Retni A, Ayuba A. (2021). Faktor–faktor yang berhubungan dengan kejadian anemia pada pasien penyakit gagal ginjal kronik di ruang hemodialisa rsud prof. dr. h. aloei saboe kota gorontalo (Factors associated with the incidence of anemia in patients with chronic kidney disease in the hemodialysis room at Prof. Hospital. Dr. h. Aloei Saboe, Gorontalo City). Zaitun. (Med Science J). 4(1).
Riskesdas T (2018). Laporan nasional ris-kesdas 2018 (2018 national riskesdas report). Kementerian Kesehatan RI. doi: 10.12688/f1-000research.465-44.1.
Salman M, Khan AH, Adnan AS, Sulaiman SAS, Hussain K, Shehzadi N, Islam M, et al. (2016). Prevalence and management of anemia in pre-dialysis Malaysian patients: A hospital-based study. Rev Assoc Med Bras. 62(8): 742-747. http://dx.doi.org/10.1590/1806-9282-.62.08.742.
Sudoyo AW, Setiyohadi B, Alwi I, ilmu penyakit dalam edisi VI (Textbook of disease sciences in VI edition). Jakarta Pusat. Intenal publishing.
